Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.999,31
-0,39%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Intrexon Corporation (XON) Intrexon Corporation (XON) Notizie

XON

Intrexon (XON)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XON
DataOraFonteTitoloSimboloCompagnia
26/01/202122:05PR Newswire (US)Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional SharesNASDAQ:XONIntrexon Corporation
06/01/202114:05PR Newswire (US)Precigen to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:XONIntrexon Corporation
09/11/202014:05PR Newswire (US)Precigen Reports Third Quarter 2020 and Year-to-Date Financial ResultsNASDAQ:XONIntrexon Corporation
02/11/202022:05PR Newswire (US)Precigen to Announce Third Quarter 2020 Financial Results on November 9th: Will host Pipeline and Data Update Call in Early D...NASDAQ:XONIntrexon Corporation
04/06/202022:24Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XONIntrexon Corporation
04/06/202022:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XONIntrexon Corporation
19/05/202022:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XONIntrexon Corporation
11/05/202023:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XONIntrexon Corporation
29/04/202012:25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XONIntrexon Corporation
02/03/202022:57Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XONIntrexon Corporation
14/02/202020:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XONIntrexon Corporation
11/02/202023:08Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:XONIntrexon Corporation
06/02/202022:25Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:XONIntrexon Corporation
04/02/202023:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XONIntrexon Corporation
03/02/202013:30PR Newswire (US)Precigen Completes Series Of Transactions To Solidify Healthcare FocusNASDAQ:XONIntrexon Corporation
22/01/202012:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XONIntrexon Corporation
09/01/202013:30PR Newswire (US)Triple-Gene Announces Presentation at Upcoming Biotech Showcase Investor ConferenceNASDAQ:XONIntrexon Corporation
06/01/202013:30PR Newswire (US)Precigen Receives FDA Orphan Drug Designation for PRGN-3006 UltraCAR-T™ in Patients with Acute Myeloid Leukemia (AML)NASDAQ:XONIntrexon Corporation
02/01/202016:33PR Newswire (US)Darling Ingredients Acquires 100% of EnviroFlightNASDAQ:XONIntrexon Corporation
02/01/202013:55PR Newswire (US)Intrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen...NASDAQ:XONIntrexon Corporation
18/11/201913:30PR Newswire (US)Triple-Gene Presented Preliminary Phase 1 Trial Data of Investigational Multigenic Therapeutic Candidate INXN‑4001 for Trea...NASDAQ:XONIntrexon Corporation
12/11/201913:30PR Newswire (US)Intrexon Reports Third Quarter 2019 Financial ResultsNASDAQ:XONIntrexon Corporation
07/11/201913:30PR Newswire (US)Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN‑4001, First Multigenic Investigational T...NASDAQ:XONIntrexon Corporation
04/11/201922:05PR Newswire (US)Intrexon to Announce Third Quarter Financial Results on November 12thNASDAQ:XONIntrexon Corporation
22/10/201901:37Dow Jones NewsOil Search Scales Back Production GuidanceNASDAQ:XONIntrexon Corporation
24/09/201910:00GlobeNewswire Inc.Next Green Wave Achieves Operational Milestones For Intrexon’s Botticelli™ Cannabis Plantlet ProductionNASDAQ:XONIntrexon Corporation
19/08/201913:30PR Newswire (US)ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patie...NASDAQ:XONIntrexon Corporation
12/08/201912:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XONIntrexon Corporation
08/08/201923:15PR Newswire (US)Intrexon Reports Second Quarter and First Half 2019 Financial ResultsNASDAQ:XONIntrexon Corporation
05/08/201913:30PR Newswire (US)Precigen Announces First Patient Dosed in Phase 1 Study of PRGN-3005 UltraCAR-T™ in Patients with Advanced, Recurrent Plati...NASDAQ:XONIntrexon Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XON

La tua Cronologia

LSE
12ZB
Barclays 23
KUCN
GEEQUSDT
Geeq
BIT
F15501
Vontobel Financial Produ...
BOV
MRSA5B
Mrs Logistica PNA
COIN
TCJETH
CoinShare
BITMOT
851678
Italy Tf 2,875% Ot29 Usd
EU
CDCLL
Caisse des Depots et Con...
AMEX
DMU
BIT
P1JUG7
BNP Paribas Issuance
NASDAQ
ENSG
Ensign
LBNK
PINSUSDT
PINs Network Token
LSE
0M8Z
Glintt Global Intelligen...
NASDAQ
VRSK
Verisk Analytics
BIT
HSGE
HSBC ICAV GL SUS Gov Bon...
BIT
Q00146
Leonteq Securities
BIT
UB2Y60
UniCredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network